- Home
- WU vs OCUL Comparison
WU vs OCUL Comparison
Compare WU & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WU
- OCUL
- Stock Information
- Founded
- WU 1851
- OCUL 2006
- Country
- WU United States
- OCUL United States
- Employees
- WU N/A
- OCUL N/A
- Industry
- WU Business Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- WU Consumer Discretionary
- OCUL Health Care
- Exchange
- WU Nasdaq
- OCUL Nasdaq
- Market Cap
- WU 2.6B
- OCUL 2.3B
- IPO Year
- WU 2006
- OCUL 2014
- Fundamental
- Price
- WU $8.36
- OCUL $12.17
- Analyst Decision
- WU Hold
- OCUL Strong Buy
- Analyst Count
- WU 10
- OCUL 7
- Target Price
- WU $8.69
- OCUL $17.83
- AVG Volume (30 Days)
- WU 8.5M
- OCUL 2.2M
- Earning Date
- WU 10-22-2025
- OCUL 11-13-2025
- Dividend Yield
- WU 11.26%
- OCUL N/A
- EPS Growth
- WU 61.96
- OCUL N/A
- EPS
- WU 2.65
- OCUL N/A
- Revenue
- WU $4,103,899,999.00
- OCUL $56,664,000.00
- Revenue This Year
- WU $0.22
- OCUL N/A
- Revenue Next Year
- WU $0.66
- OCUL $18.87
- P/E Ratio
- WU $3.14
- OCUL N/A
- Revenue Growth
- WU N/A
- OCUL N/A
- 52 Week Low
- WU $7.89
- OCUL $5.79
- 52 Week High
- WU $12.40
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- WU 45.81
- OCUL 46.53
- Support Level
- WU $8.00
- OCUL $12.27
- Resistance Level
- WU $8.50
- OCUL $13.07
- Average True Range (ATR)
- WU 0.19
- OCUL 0.62
- MACD
- WU -0.05
- OCUL -0.10
- Stochastic Oscillator
- WU 37.89
- OCUL 7.92
About WU Western Union Company (The)
Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2024 and is the largest money transfer company in the world.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.